The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
The company also announced a major portfolio shift, planning to divest its Immunodiagnostics business in China, a unit that generated approximately 6% of its fiscal 2025 revenue
Conceptualized as an aggregator platform it integrates existing programme systems through an API-based federated architecture
AI-enabled technology platform delivers integrated pharmacovigilance solutions with measurable efficiency gains and enhanced compliance
Designed for high-throughput genomic analysis, the laboratory enables accurate, consistent, and scalable testing, delivering high standards of reporting excellence
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
The transaction marks a clear portfolio reshuffle for Indoco
Subscribe To Our Newsletter & Stay Updated
